HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required)
HHS Awards $4.8 Million to Organizations Advancing Community-Driven Approaches to Tackling Structural Racism
Enhance access to justice for individuals from groups vulnerable to social exclusion through education on human rights and access to legal aid services
HHS Announces Health Resources and Services Administration-Funded Health Centers Partnering With National Cancer Institute-Designated Cancer Centers to Improve Equity in Cancer Screening
AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) (Letter of Intent Due Date(s) – Oct 14)
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-051, “HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 – Clinical Trials Optional)”
New Funding Opportunity for Research on Fostering Behavioral Health Among Children in School (Due by Oct 28)
HHS announces award of $2 million grant to the American Academy of Pediatrics to establish National Center of Excellence on Social Media and Mental Wellness
Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People (First available due date: Sept 25)
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) (Letter of intent due date: 30 days prior to the application due date)
Notice of Intent to Publish a Funding Opportunity Announcement for Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 – Clinical Trial Optional)
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) (Letter of intent 30 days prior to each application due date, first application due date: Nov 14)
Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes (First available due date: Oct 5)
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) (First application due date: Dec 7)